Product Information
DEXMETHYLPHENIDATE 5 MG TAB is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.2698 per EA under NDC 75834032701. Its NADAC has been published 94 times since Dec 18, 2024.
FDA first approved this application on Sep 19, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834032701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXMETHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209211FDA Approved
9/19/2018
TE Code
AB
On Market Since
5/3/2024
Pharmacological Classes
Price Statistics
The NADAC for DEXMETHYLPHENIDATE 5 MG TAB has been published 94 times since Dec 18, 2024, and over the history we have for it it has risen 5.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2698 per EA |
|---|---|
| All-time high | $0.2933 (Jul 16, 2025) |
| All-time low | $0.2557 (Dec 18, 2024) |
| 52-week high | $0.2915 |
| 52-week low | $0.2638 |
| Median price | $0.2728 |
| Average price | $0.2759 |
| Largest weekly change | -7.7% (Aug 20, 2025) |
| Weeks tracked | 94 |
| Tracking since | Dec 18, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Nivagen Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dexmethylphenidate hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central Nervous System Stimulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DEXMETHYLPHENIDATE 5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DEXMETHYLPHENIDATE 5 MG TAB, manufactured by Nivagen Pharmaceuticals Inc., is $0.2698 per EA (NDC 75834032701), effective Sep 30, 2026.
How has the price of DEXMETHYLPHENIDATE 5 MG TAB changed over time?
Over the history we have for it, the NADAC for DEXMETHYLPHENIDATE 5 MG TAB has risen 5.5%. It has been tracked across 94 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for DEXMETHYLPHENIDATE 5 MG TAB?
Since Dec 18, 2024, the NADAC for DEXMETHYLPHENIDATE 5 MG TAB has ranged from a low of $0.2557 (Dec 18, 2024) to a high of $0.2933 (Jul 16, 2025), with a median of $0.2728 per EA.
Are there cheaper alternatives to DEXMETHYLPHENIDATE 5 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DEXMETHYLPHENIDATE 5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures DEXMETHYLPHENIDATE 5 MG TAB?
DEXMETHYLPHENIDATE 5 MG TAB (NDC 75834032701) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.